Haemonetics Stock Technical Analysis
| HAE Stock | USD 70.02 0.09 0.13% |
As of the 23rd of January, Haemonetics retains the Market Risk Adjusted Performance of (4.37), risk adjusted performance of 0.1078, and Downside Deviation of 2.09. Haemonetics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Haemonetics information ratio, value at risk, and the relationship between the standard deviation and treynor ratio to decide if Haemonetics is priced fairly, providing market reflects its last-minute price of 70.02 per share. Given that Haemonetics has jensen alpha of 0.5845, we strongly advise you to confirm Haemonetics's regular market performance to make sure the company can sustain itself at a future point.
Haemonetics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Haemonetics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HaemoneticsHaemonetics | Build AI portfolio with Haemonetics Stock |
Haemonetics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 92.0 | Buy | 10 | Odds |
Most Haemonetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Haemonetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Haemonetics, talking to its executives and customers, or listening to Haemonetics conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.227 | Earnings Share 3.42 | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Haemonetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Haemonetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Haemonetics.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Haemonetics on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Haemonetics or generate 0.0% return on investment in Haemonetics over 90 days. Haemonetics is related to or competes with Marti Technologies, TIM Participacoes, C4 Therapeutics, MicroCloud Hologram, Immersion, Horizon Technology, and Liberty Live. Haemonetics Corporation, a healthcare company, provides medical products and solutions More
Haemonetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Haemonetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Haemonetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.09 | |||
| Information Ratio | 0.1107 | |||
| Maximum Drawdown | 37.26 | |||
| Value At Risk | (3.11) | |||
| Potential Upside | 3.1 |
Haemonetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Haemonetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Haemonetics' standard deviation. In reality, there are many statistical measures that can use Haemonetics historical prices to predict the future Haemonetics' volatility.| Risk Adjusted Performance | 0.1078 | |||
| Jensen Alpha | 0.5845 | |||
| Total Risk Alpha | 0.0223 | |||
| Sortino Ratio | 0.2288 | |||
| Treynor Ratio | (4.38) |
Haemonetics January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1078 | |||
| Market Risk Adjusted Performance | (4.37) | |||
| Mean Deviation | 1.71 | |||
| Semi Deviation | 1.4 | |||
| Downside Deviation | 2.09 | |||
| Coefficient Of Variation | 741.82 | |||
| Standard Deviation | 4.32 | |||
| Variance | 18.65 | |||
| Information Ratio | 0.1107 | |||
| Jensen Alpha | 0.5845 | |||
| Total Risk Alpha | 0.0223 | |||
| Sortino Ratio | 0.2288 | |||
| Treynor Ratio | (4.38) | |||
| Maximum Drawdown | 37.26 | |||
| Value At Risk | (3.11) | |||
| Potential Upside | 3.1 | |||
| Downside Variance | 4.37 | |||
| Semi Variance | 1.95 | |||
| Expected Short fall | (1.82) | |||
| Skewness | 6.21 | |||
| Kurtosis | 46.16 |
Haemonetics Backtested Returns
Haemonetics appears to be very steady, given 3 months investment horizon. Haemonetics holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13 % return per unit of risk over the last 3 months. By evaluating Haemonetics' technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please utilize Haemonetics' Risk Adjusted Performance of 0.1078, downside deviation of 2.09, and Market Risk Adjusted Performance of (4.37) to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Haemonetics holds a performance score of 10. The company retains a Market Volatility (i.e., Beta) of -0.13, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Haemonetics are expected to decrease at a much lower rate. During the bear market, Haemonetics is likely to outperform the market. Please check Haemonetics' total risk alpha, value at risk, and the relationship between the standard deviation and treynor ratio , to make a quick decision on whether Haemonetics' current trending patterns will revert.
Auto-correlation | -0.54 |
Good reverse predictability
Haemonetics has good reverse predictability. Overlapping area represents the amount of predictability between Haemonetics time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Haemonetics price movement. The serial correlation of -0.54 indicates that about 54.0% of current Haemonetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.54 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 18.69 |
Haemonetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Haemonetics Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Haemonetics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Haemonetics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Haemonetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Haemonetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Haemonetics price pattern first instead of the macroeconomic environment surrounding Haemonetics. By analyzing Haemonetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Haemonetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Haemonetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Dividend Yield | 0.0122 | 0.011 | 0.00976 | Price To Sales Ratio | 2.34 | 3.28 | 2.14 |
Haemonetics January 23, 2026 Technical Indicators
Most technical analysis of Haemonetics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Haemonetics from various momentum indicators to cycle indicators. When you analyze Haemonetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1078 | |||
| Market Risk Adjusted Performance | (4.37) | |||
| Mean Deviation | 1.71 | |||
| Semi Deviation | 1.4 | |||
| Downside Deviation | 2.09 | |||
| Coefficient Of Variation | 741.82 | |||
| Standard Deviation | 4.32 | |||
| Variance | 18.65 | |||
| Information Ratio | 0.1107 | |||
| Jensen Alpha | 0.5845 | |||
| Total Risk Alpha | 0.0223 | |||
| Sortino Ratio | 0.2288 | |||
| Treynor Ratio | (4.38) | |||
| Maximum Drawdown | 37.26 | |||
| Value At Risk | (3.11) | |||
| Potential Upside | 3.1 | |||
| Downside Variance | 4.37 | |||
| Semi Variance | 1.95 | |||
| Expected Short fall | (1.82) | |||
| Skewness | 6.21 | |||
| Kurtosis | 46.16 |
Haemonetics January 23, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Haemonetics stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 33,461 | ||
| Daily Balance Of Power | (0.05) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 70.80 | ||
| Day Typical Price | 70.54 | ||
| Price Action Indicator | (0.82) |
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |